Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT07493863 for Ergonomics, Virtual Reality Headset, Virtual Reality, Endoscopy is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Feasibility and Ergonomic Impact of A Virtual Reality Headset in Endoscopic Procedures 140 Virtual
Clinical Trial NCT07493863 is an interventional study for Ergonomics, Virtual Reality Headset, Virtual Reality, Endoscopy that is recruiting. It started on 10 March 2026 with plans to enroll 140 participants. Led by The Cleveland Clinic, it is expected to complete by 1 December 2026. The latest data from ClinicalTrials.gov was last updated on 25 March 2026.
Brief Summary
The purpose of this study is to assess the feasibility of using a virtual reality headset (VRH) during endoscopy and its impact on the endoscopist ergonomics. We will use the Apple Vision Pro during approximately 140 endoscopic procedures during which ergonomics will be assessed.
Official Title
Feasibility and Ergonomic Impact of A Virtual Reality Headset in Endoscopic Procedures
Conditions
ErgonomicsVirtual Reality HeadsetVirtual RealityEndoscopyOther Study IDs
- 26-072
NCT ID Number
Start Date (Actual)
2026-03-10
Last Update Posted
2026-03-25
Completion Date (Estimated)
2026-12
Enrollment (Estimated)
140
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
ergonomics
virtual reality
virtual reality headset
endoscopy
virtual reality
virtual reality headset
endoscopy
Primary Purpose
Prevention
Design Allocation
Non-Randomized
Interventional Model
Sequential
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
Active ComparatorNonVRH Endoscopic procedure without virtual reality headset (VRH) | MYSELF checklist A preprocedural timeout to improve ergonomics. |
Active ComparatorVRH Endoscopic procedure completed with virtual reality headset (VRH) | Virtual Reality Headset Use of the virtual reality headset during endoscopic procedures. MYSELF checklist A preprocedural timeout to improve ergonomics. |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Risk Reduction of endoscopy related musculoskeletal injury by VRH as assessed by rapid entire body assessment (REBA) score. | The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant. | From the start until the end of an endoscopic procedure. |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Endoscopist experience with VRH assess via subjective survey scored on a 5-point Likert scale. | The survey includes six questions on ergonomics, technical feasibility, visual clarity, workflow, mental demands, and overall experience. Each question is scored 1-5 with the higher score being outcome. | From the start until the end of an endoscopic procedure. |
Risk reduction of endoscopic related musculoskeletal injury in specific subgroups (colonoscopy, EUS, ERCP) by VRH as assessed by rapid entire body assessment (REBA) score. | The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant. | From the start until the end of an endoscopic procedure. |
risk reduction of endoscopy related musculoskeletal injury due to pre-procedural checklist as assessed by rapid entire body assessment (REBA) score. | The REBA score is an ergonomic assessment tool used to identify potential risks of musculoskeletal disorders in the workplace by evaluating posture and movements. The score ranges from 0-15 with 0 being the lowest risk and 15 being the highest risk. A two point decrease pre-intervention will be considered significant. | From the start until the end of an endoscopic procedure. |
Participation Assistant
Eligibility Criteria
Eligible Ages
Child, Adult, Older Adult
Eligible Sexes
All
Accepts Healthy Volunteers
Yes
- Endoscopist: endoscopist at Cleveland Clinic Weston who consent to participate in the study and are performing either colonoscopy, EUS, or ERCP.
- Patient: patient undergoing colonoscopy, EUS, or ERCP
- Exclude the following procedures: Device-assisted colonoscopy (e.g.- double balloon, pathfinder, etc)
- ERCP in native papilla
- Cholangioscopy
- Therapeutic EUS procedures (FNA/FNB, Stent Placement)
- Planned Mucosal Resection of Polyps > 20 mm
- Inpatient procedures
- Aborted procedures
Study Responsible Party
Shah,Tilak, Principal Investigator, Medical Director, National Pancreas Center of Excellence, Advanced Therapeutic Endoscopy, The Cleveland Clinic
No contact data.
1 Study Locations in 1 Countries
Florida
Cleveland Clinic Weston, Weston, Florida, 33331, United States
Tilak Shah, MD, Contact, 877.463.2010, [email protected]
Recruiting